BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study.
Xiaoqing LiLan SunAndres StuckyLingli TuJin CaiXuelian ChenZhongjun WuXuhong JiangShengwen Calvin LiPublished in: Diagnostics (Basel, Switzerland) (2021)
variants are associated with significantly improved clinical outcomes in N.B., thus providing clinicians with a new tool.